Finzati - Logo
OPRX logo

OptimizeRx Corp.

OPRX • Medical - Healthcare Information Services
$7.87
▼ -0.08 (-1.01%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$164.76M
Growth
34.4%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 13.5%Positive free cash flow · 1.01Consistent free cash flow · 4/5Manageable debt level · 0.2Healthy liquidity · 3.04
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:23 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$7.87
Change-1.01%
Market Cap$164.76M
52W Range4.54 - 22.25
Beta1.05
Gross Margin63.30%
Oper. Margin11.02%
Profit Margin4.69%
Debt/Eq0.20
Current Ratio3.04
Quick Ratio3.04
Revenue 5Y34.37%

Investment DNA

How strong this company looks for long-term investors

73
out of 100
Business Quality
Margins, moat, returns
54/100
Financial Strength
Debt, cash, stability
77/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Positive revenue growth · 13.5%Positive free cash flow · 1.01Consistent free cash flow · 4/5Manageable debt level · 0.2Healthy liquidity · 3.04Expensive earnings multiple · 44.33

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$7.00
Mean
$10.25
Median
$11.00
High
$12.00

Company Overview

IPO: 11/28/2007
Industry: Medical - Healthcare Information Services
P/B i: 1.77
Debt / Equity i: 0.20
Operating Margin: 11.02%
Net Margin: 4.69%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.20
Current Ratio: 3.04
Quick Ratio: 3.04
Status: Good

Insider Transactions

Recent executive and insider activity

WASSON GREGORY D
Transaction: 06/09/2026
BUY
Change
+34,517
Price
Not reported
Filing
06/10/2026
Type
BUY
Vos Ellen O'Connor
Transaction: 06/09/2026
BUY
Change
+34,517
Price
Not reported
Filing
06/10/2026
Type
BUY
Spangler Patrick D
Transaction: 06/09/2026
BUY
Change
+34,517
Price
Not reported
Filing
06/10/2026
Type
BUY